"Official medicines" is the best online drugstore.

World’s leading meds delivered to your door – and you don’t even need a prescription! Only certified, first class drugs on offer! Buy more and spend less with our great discount system.

The meds you need, reliable and hassle free! Top products of top brands.

The only pharmacy shop you will ever need! Approved drugs available without prescription. Best deals, unmatched service and shipping. 100% safe!


(OX-ee-KOE-dohn/ass-cet-ah-MEE-noe-fen)
Percocet
Tablets: 5 mg oxycodone HCl/325 mg acetaminophen, Tablets: 7.5 mg oxycodone HCl/500 mg acetaminophen, Tablets: 10 mg oxycodone HCl/650 mg acetaminophen, Roxicet, Tablets: 5 mg oxycodone HCl/325 mg acetaminophen, Solution, oral: 5 mg oxycodone HCl/325 mg acetaminophen, Roxicet 5/500, Caplets: 5 mg oxycodone/500 mg acetaminophen, Roxilox, Capsules: 5 mg oxycodone HCl/500 mg acetaminophen, Tylox, Capsules: 5 mg oxycodone HCl/500 mg acetaminophen, Endocet, Oxycocet, Percocet-Demi
Class: Narcotic analgesic combination

 Action Acetaminophen inhibits synthesis of prostaglandins and peripherally blocks pain impulse generation, whereas, oxycodone binds to opiate receptors in CNS. Combination has synergistic effect on alleviating pain.

 Indications Relief of moderate-to-moderately severe pain.

 Contraindications Hypersensitivity to acetaminophen, oxycodone or similar compounds.

 Route/Dosage

ADULTS: PO 5 mg (1 tablet, caplet, or teaspoonful) q 6 hr prn.

 Interactions

Anesthetics: Additive CNS depression.

Carbamazepine, hydantoins, sulfinpyrazone: Increased risk of hepatotoxicity.

CNS depressants (eg, barbiturates, tricyclic antidepressants, phenothiazines, sedatives, hypnotics, alcohol, other narcotics): Additive CNS depression.

 Lab Test Interferences With Chemstrip bG, Dextrostix, and Visidex II home blood glucose systems, may cause false decrease in mean glucose values.

 Adverse Reactions

CARDIOVASCULAR: Hypotension; bradycardia; tachycardia. CNS: Lightheadedness; dizziness; weakness; fatigue; sedation; euphoria; dysphoria; nervousness; headache; confusion. DERMATOLOGIC: Pruritus; rash. GI: Nausea; vomiting; constipation; abdominal pain; anorexia; biliary spasm; dry mouth. GU: Urinary retention or hesitancy. RESPIRATORY: Dyspnea; respiratory depression. OTHER: Malaise; tolerance; psychological and physical dependence with chronic use.

 Precautions

Pregnancy: Category C. Lactation: Undetermined. Children: Safety and efficacy not established. Special Risk Patients: Use with caution in elderly, debilitated patients and those with hepatic or kidney failure or conditions accompanied by hypoxia or hypercapnia; monitor carefully to avoid decrease in pulmonary ventilation. Also use cautiously in patients sensitive to CNS depressants, postoperatively and in patients with pulmonary disease. Acute Abdominal Conditions: Diagnosis may be obscured; use with caution. Dependence: Can produce drug dependence; has abuse potential. Head Injury: Respiratory depression and elevation of CSF pressure may be exacerbated. Hepatic Impairment: Chronic alcoholics should limit acetaminophen intake to < 2 g/day. Sulfite Sensitivity: Use with caution in patients known to be sensitive, as some products contain bisulfites.

PATIENT CARE CONSIDERATIONS

 Administration/Storage

  • Administer with food or milk to minimize GI irritation.
  • Store at room temperature in tightly-closed container.

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Assess type, location, and intensity of pain before administration and frequently during treatment.
  • Assess vital signs before administration and periodically during treatment.
  • Assess for signs of narcotic dependence.
  • Assess bowel function routinely. If constipation develops, provide additional fluids, high-fiber foods, or stool softeners.
  • If respiratory depression develops, notify health care provider immediately and prepare emergency equipment.
  • If sedation or confusion develops, take safety precautions (eg, keep side rails up, assist with ambulation).
  • Evaluate patient's continuing need for therapy since psychological and physical dependence and tolerance may develop.
OVERDOSAGE: SIGNS & SYMPTOMS
  Miosis, respiratory depression, CNS depression (somnolence progressing to stupor or coma), hepatic damage, circulatory collapse, cardiopulmonary arrest, death

 Patient/Family Education

  • Instruct patient to take medication before pain becomes severe for greatest effectiveness.
  • Teach patient methods to prevent constipation.
  • Instruct patient to make position changes slowly if lightheadedness or sedation occurs.
  • Advise patient to avoid intake of alcoholic beverages or products containing alcohol while using this medication.
  • Advise patient that drug may cause drowsiness, and to use caution while driving or performing other tasks requiring mental alertness.
  • Caution patient that physical dependency and withdrawal symptoms may occur following discontinuation of long-term therapy.
  • Instruct patient not to take any otc medications without consulting health care provider.

Popularity: 2% [?]


If you're still unable to find appropriate information in the article, please use search form below